1. |
Devesa S, Blot W, Stone B. Recent cancer trends in the United States. J Natl Cancer Inst, 1995, 87:175-182.
|
2. |
Parkin D, Bray F, Ferlay J. Global cancer statistics 2002. CA Cancer J Clin, 2005, 55:74-108.
|
3. |
Lemal A, Siegel R, Ward E. Cancer statistics, 2008. CA Cancer J Clin, 2008, 58:71-96.
|
4. |
Hidalgo M. Pancreatic Cancer. N Engl J Med, 2010, 362:1605-1617.
|
5. |
Gudjonssun B. Pancreatic cancer:survival, errors and incidence. Eur J Gastroenterol Hepatol, 2009, 21:1379-1382.
|
6. |
吕文超, 崔云甫, 钟翔宇. 胰腺癌流行病学研究进展. 世界华人消化杂志, 2011, 19(27):2805-2809.
|
7. |
陈尹, 胡世莲,李幼平, 等. 全球药物干预治疗单纯性高血压指南的系统评价. 中国循证医学杂志, 2012, 12(10):1180-1194.
|
8. |
Schmidt S, Follmann M, Malek N, et al. Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma. J Gastroenterol Hepatol, 2011, 26(12):1779-1786.
|
9. |
Yamaguchi K, Tanaka M. EBM-based Clinical Guidelines for Pancreatic Cancer 2009 from the Japan Pancreas Society:a synopsis. Jpn J Clin Oncol, 2011, 41(7):836-840.
|
10. |
李槐. 胰腺癌经动脉灌注化疗指南(草案). 介入放射学杂志, 2012, 21(5):353-355.
|
11. |
中华人民共和国国家卫生和计划生育委员会. 胰腺癌诊疗规范(2011年版). 2011.
|
12. |
复旦大学附属肿瘤医院肝胆胰综合治疗组. 胰腺癌诊治指南. 2010.
|
13. |
赵玉沛. 胰腺癌诊治指南. 中国实用外科杂志, 2007, 27(9):671-673.
|
14. |
Pancreatic Section of the British Society of Gastroenterology, et al. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut, 2005, 54(Suppl 5):v1-v16.
|
15. |
van Laethem JL, Verslype C, Iovanna JL, et al. New strategies and designs in pancreatic cancer research:consensus guidelines report from a European expert panel. Ann Oncol, 2012, 23(3):570-576.
|
16. |
Cascinu S, Falconi M, Valentini V, et al. Pancreatic cancer:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2010, 21(Suppl 5):v55-58.
|
17. |
National Institute for Clinical Excellence. Technology appraisal No.25.Guidance on the use of gemcitabine for the treatment of pancreatic cancer.2001. Avialable at:http://www.nice.org.uk/nicemedia/live/11425/32185/32185.pdf.
|
18. |
Tempero MA, Arnoletti JP, Behrman SW, et al. Pancreatic Adenocarcinoma, version 2.2012:featured updates to the NCCN Guidelines. J Natl Compr Canc Netw, 2012, 10(6):703-713.
|
19. |
Jonker D, Bouttell E, Kamra J, et al. Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma. Program in Evidencebased Care Evidence-based Series, 2-23 Version 2.
|
20. |
Earle CC, Agboola O, Maroun J, et al. The treatment of locally advanced pancreatic cancer:a practice guideline. Can J Gastroenterol, 2003, 17(3):161-167.
|
21. |
Russo SM, Ove R, Saif MW. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco CA USA. JOP, 2011, 12(2):92-95.
|
22. |
Pancreatic Cancer. Available at:www.gicancer.org.au.
|
23. |
丁琳, 唐海沁, 李结华, 等. 中国慢病防治指南现状分析及评价. 中国循证心血管医学杂志, 2012, 4(4):308-312.
|
24. |
张伶俐, 李幼平, 张川, 等. 中国儿童临床指南现状分析及循证临床指南评价. 中国循证医学杂志, 2011, 11(9):991-999.
|